Sees Q3: Revenue from pharma tests and services, and all other customers to be in the range of $11.0 to $13.0 million. Revenue from population sequencing and enterprise sales of approximately $1.0 million
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSNL: